Fastenal vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 86)

Fastenal

LeaderManufacturing

Enterprise

Winona MN industrial distribution (NASDAQ: FAST) at $7.55B FY2024 revenue (+2.7%); 100,000+ vending units + 1,600 Onsite embedded locations at manufacturing plants, net income $1.15B competing with Grainger and MSC.

AI VisibilityBeta
Overall Score
A86
Category Rank
#100 of 290
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
83
Gemini
83

About

Fastenal Company is a Winona, Minnesota-based industrial distribution company — publicly traded on NASDAQ (NASDAQ: FAST) as an S&P 500 Industrials component — distributing fasteners (bolts, nuts, screws, anchors), safety products, cutting tools, chemicals, electrical supplies, and other manufacturing and maintenance supplies through approximately 3,400 branches, 100,000+ vending units at customer facilities, and 1,600+ Onsite locations embedded at customer manufacturing plants, through approximately 22,000 employees. In fiscal year 2024, Fastenal reported annual revenue of $7.55 billion (+2.71% year-over-year) and net income of $1.15 billion — modest growth reflecting the challenging industrial manufacturing environment where factory output and MRO spending growth was constrained by cautious capital investment from manufacturing customers. CEO Dan Florness leads Fastenal's industry-leading managed inventory strategy — the FMI (Fastenal Managed Inventory) technology platform — combining vending machines, RFID-tracked lockers, and Onsite team members to help manufacturing customers reduce working capital tied up in fastener and MRO inventory while ensuring product availability exactly when production needs it. Fastenal's Onsite model (dedicated Fastenal employees working full-time inside customer manufacturing facilities to manage supply needs) now represents approximately 1,600 Onsite locations generating strong productivity per Fastenal employee, reflecting the company's evolution from a counter-top distribution branch model to an embedded supply chain partner.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

86
Overall Score
90
#100
Category Rank
#9
68
AI Consensus
60
stable
Trend
stable
94
ChatGPT
99
83
Perplexity
99
83
Gemini
83
85
Claude
96
92
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.